Roche enjoys LM success as bonds wobble
Hoffmann-La Roche, the highly rated Swiss pharmaceuticals group, this week bought back £400m of bonds in a liability management exercise which was oversubscribed at the best possible price for the issuer.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts